The kringle stabilizes urokinase binding to the urokinase receptor

被引:54
作者
Bdeir, K
Kuo, A
Sachais, BS
Rux, AH
Bdeir, Y
Mazar, A
Higazi, AAR
Cines, DB
机构
[1] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[3] Attenuon, San Diego, CA USA
[4] Hadassah Med Org, Dept Clin Biochem, Jerusalem, Israel
关键词
D O I
10.1182/blood-2003-03-0949
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The structural basis of the interaction between single-chain urokinase-type plasminogen activator (scuPA) and its receptor (uPAR) is incompletely defined. Several observations indicated the kringle facilitates the binding of uPA to uPAR. A scuPA variant lacking the kringle (DeltaK-scuPA) bound to soluble uPAR (suPAR) with the similar "on-rate" but with a faster "off-rate" than wild-type (WT)-scuPA. Binding of DeltaK-scuPA, but not WT-scuPA, to suPAR was comparably inhibited by its growth factor domain (GFD) and amino-terminal fragment (ATF). ATF and WT-scuPA, but not GFD, scuPA lacking the GFD (DeltaGFD-scuPA), or DeltaK-scuPA reconstituted the isolated domains of uPAR. ATF completely inhibited the enzymatic activity of WT-scuPA-suPAR unlike comparable concentrations of GFD. Variants containing mutations that alter the charge, length, or flexibility of linker sequence (residues 43-49) between the GFD and the kringle displayed a lower affinity for uPAR, were unable to reconstitute uPAR domains, and their binding to uPAR was inhibited by GFD in the same manner as DeltaK-scuPA. A scuPA variant in which the charged amino acids in the heparin binding site (HBS) in the kringle domain were mutated to alanines behaved like DeltaK-scuPA, indicating that that the structure of the kringle as well as its interaction with the GFD govern receptor binding. These data demonstrate an important role for the kringle in stabilizing the binding of scuPA to uPAR. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3600 / 3608
页数:9
相关论文
共 70 条
[1]   Human/chicken urokinase chimeras demonstrate sequences outside the serine protease domain that dictate autoactivation [J].
Aimes, RT ;
Regazzoni, K ;
Quigley, JP .
THROMBOSIS AND HAEMOSTASIS, 2003, 89 (02) :382-392
[2]  
APPELLA E, 1987, J BIOL CHEM, V262, P4437
[3]   EXPRESSION OF HUMAN RECOMBINANT PLASMINOGEN ACTIVATORS ENHANCES INVASION AND EXPERIMENTAL METASTASIS OF H-RAS-TRANSFORMED NIH 3T3 CELLS [J].
AXELROD, JH ;
REICH, R ;
MISKIN, R .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (05) :2133-2141
[4]  
BARNATHAN ES, 1990, J BIOL CHEM, V265, P2865
[5]   Urokinase mediates fibrinolysis in the pulmonary microvasculature [J].
Bdeir, K ;
Murciano, JC ;
Tomaszewski, J ;
Koniaris, L ;
Martinez, J ;
Cines, DB ;
Muzykantov, VR ;
Higazi, AAR .
BLOOD, 2000, 96 (05) :1820-1826
[6]   A region in domain II of the urokinase receptor required for urokinase binding [J].
Bdeir, K ;
Kuo, A ;
Mazar, A ;
Sachais, BS ;
Xiao, WZ ;
Gawlak, S ;
Harris, S ;
Higazi, A ;
Cines, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28532-28538
[7]   Domain interplay in the urokinase receptor - Requirement for the third domain in high affinity ligand binding and demonstration of ligand contact sites in distinct receptor domains [J].
Behrendt, N ;
Ronne, E ;
Dano, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22885-22894
[8]   Urokinase-type plasminogen activator induces tyrosine phosphorylation of a 78-kDa protein in H-157 cells [J].
Bhat, GJ ;
Gunaje, JJ ;
Idell, S .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 277 (02) :L301-L309
[9]   REVERSIBLE INDEPENDENT UNFOLDING OF THE DOMAINS OF UROKINASE MONITORED BY H-1-NMR [J].
BOGUSKY, MJ ;
DOBSON, CM ;
SMITH, RAG .
BIOCHEMISTRY, 1989, 28 (16) :6728-6735
[10]   Inhibition of the interaction of urokinase-type plasminogen activator (uPA) with its receptor (uPAR) by synthetic peptides [J].
Burgle, M ;
Koppitz, M ;
Riemer, C ;
Kessler, H ;
Konig, B ;
Weidle, UH ;
Kellermann, J ;
Lottspeich, F ;
Graeff, H ;
Schmitt, M ;
Goretzki, L ;
Reuning, U ;
Wilhelm, O ;
Magdolen, V .
BIOLOGICAL CHEMISTRY, 1997, 378 (3-4) :231-237